News on Vectech Pharmaceutical Consultants%2C Inc from BioPortfolio.com http://www.BioPortfolio.com Consolidated Vectech Pharmaceutical Consultants%2C Inc news from BioPortfolio.com Wed, 10 Feb 2010 03:55:39 GMT en FSMB Names Todd Phillips CFOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039345&HITNO=0&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039345&THISHREF=http://c.moreover.com/click/here.pl%3fz2538045436%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039345&HITNO=0&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039345&THISHREF=http://c.moreover.com/click/here.pl%3fz2538045436%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewswise: Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026832&HITNO=1&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026832&THISHREF=http://c.moreover.com/click/here.pl%3fz2531375729%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026832&HITNO=1&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026832&THISHREF=http://c.moreover.com/click/here.pl%3fz2531375729%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: IPC acquires hospitalist practice of Arizona Medical Serviceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024435&HITNO=2&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024435&THISHREF=http://c.moreover.com/click/here.pl%3fz2528895230%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024435&HITNO=2&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024435&THISHREF=http://c.moreover.com/click/here.pl%3fz2528895230%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024551&HITNO=3&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024551&THISHREF=http://c.moreover.com/click/here.pl%3fz2528986411%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024551&HITNO=3&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024551&THISHREF=http://c.moreover.com/click/here.pl%3fz2528986411%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Georgia card group joins Piedmonthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025409&HITNO=4&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025409&THISHREF=http://c.moreover.com/click/here.pl%3fz2529745533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025409&HITNO=4&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025409&THISHREF=http://c.moreover.com/click/here.pl%3fz2529745533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCardiovascular Business: Adex Grants Options to Directors, Officers and Certain Employees and Consultantshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019580&HITNO=5&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019580&THISHREF=http://c.moreover.com/click/here.pl%3fz2526378226%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019580&HITNO=5&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019580&THISHREF=http://c.moreover.com/click/here.pl%3fz2526378226%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Paloma Pharmaceuticals receives FDA approval to enter Phase I studies with P529http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018790&HITNO=6&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018790&THISHREF=http://c.moreover.com/click/here.pl%3fz2525938447%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018790&HITNO=6&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018790&THISHREF=http://c.moreover.com/click/here.pl%3fz2525938447%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018043&HITNO=7&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018043&THISHREF=http://c.moreover.com/click/here.pl%3fz2525446927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018043&HITNO=7&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018043&THISHREF=http://c.moreover.com/click/here.pl%3fz2525446927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Paloma Pharmaceuticals, Inc. Receives Approval to Enter Phase I Clinical Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014210&HITNO=8&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014210&THISHREF=http://c.moreover.com/click/here.pl%3fz2523930514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014210&HITNO=8&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014210&THISHREF=http://c.moreover.com/click/here.pl%3fz2523930514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013511&HITNO=9&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013511&THISHREF=http://c.moreover.com/click/here.pl%3fz2523741649%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013511&HITNO=9&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013511&THISHREF=http://c.moreover.com/click/here.pl%3fz2523741649%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: Paloma Pharmaceuticals recibe la aprobacin para realizar ensayos clnicos en Fase Ihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016689&HITNO=10&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016689&THISHREF=http://c.moreover.com/click/here.pl%3fz2524844455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016689&HITNO=10&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016689&THISHREF=http://c.moreover.com/click/here.pl%3fz2524844455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSys-Con Media: Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014447&HITNO=11&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014447&THISHREF=http://c.moreover.com/click/here.pl%3fz2524007532%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014447&HITNO=11&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014447&THISHREF=http://c.moreover.com/click/here.pl%3fz2524007532%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Antonio Business Journal: Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014259&HITNO=12&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014259&THISHREF=http://c.moreover.com/click/here.pl%3fz2523946680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014259&HITNO=12&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014259&THISHREF=http://c.moreover.com/click/here.pl%3fz2523946680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013680&HITNO=13&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013680&THISHREF=http://c.moreover.com/click/here.pl%3fz2523805450%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013680&HITNO=13&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013680&THISHREF=http://c.moreover.com/click/here.pl%3fz2523805450%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013667&HITNO=14&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013667&THISHREF=http://c.moreover.com/click/here.pl%3fz2523800966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013667&HITNO=14&MSIZE=126&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vectech%20Pharmaceutical%20Consultants,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013667&THISHREF=http://c.moreover.com/click/here.pl%3fz2523800966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: